An 81-year-old woman is urgently evaluated on the medical-surgical unit for acute respiratory distress. She was admitted two days prior for treatment of pyelonephritis and bacteremia, initially receiving 3.5 liters of crystalloid resuscitation along with empiric intravenous piperacillin-tazobactam and vancomycin. Her past medical history includes heart failure with preserved ejection fraction, severe chronic obstructive pulmonary disease (COPD), and hypertension. Today, her blood cultures from admission are finalized, showing growth of Escherichia coli that is susceptible to ceftriaxone but resistant to ampicillin. Currently, she appears anxious and is breathing rapidly. Vital signs are temperature 37.0°C (98.6°F), blood pressure 152/88 mm Hg, heart rate 106/min, and respiratory rate 26/min. Oxygen saturation is 89% on room air. Examination shows jugular venous distention to 12 cm H2O. Auscultation reveals dullness to percussion at the bases with crackles extending halfway up the lung fields. Trace wheezing is also noted. Bilateral lower extremities exhibit 2+ pitting edema.
Laboratory studies drawn an hour ago show:
Leukocyte count: 11,200/mm³
Thyroid-stimulating hormone (TSH): 7.2 mU/L (normal: 0.5–5.0 mU/L)
Free thyroxine (T4): 1.1 ng/dL (normal: 0.9–1.7 ng/dL)
Arterial blood gas (room air):
pH: 7.22
PaCO2: 42 mm Hg
PaO2: 58 mm Hg
HCO3−: 17 mEq/L
Which of the following is the most appropriate next step in the management of this patient?
- AContinue intravenous piperacillin-tazobactam and vancomycin
- Administer intravenous furosemideCevap
- CAdminister intravenous sodium bicarbonate
- DInitiate oral levothyroxine
- EAdminister nebulized albuterol and ipratropium